Search Ontology:
ChEBI
luteolin
- Term ID
- CHEBI:15864
- Synonyms
-
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
- 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one
- 3',4',5,7-Tetrahydroxyflavone
- 5,7,3',4'-Tetrahydroxyflavone
- digitoflavone
- flacitran
- Luteolin
- Luteolol
- Salifazide
- Definition
- A tetrahydroxyflavone in which the four hydroxy groups are located at positions 3', 4', 5 and 7. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an anti-inflammatory agent and an immune system modulator as well as being active against several cancers.
- References
-
- cas:491-70-3
- chemspider:4444102
- drugbank:DB15584
- foodb.food:FDB013255
- hmdb:HMDB0005800
- kegg.compound:C01514
- knapsack:C00000674
- lincs.smallmolecule:LSM-5229
- lipidmaps:LMPK12110006
- metacyc.compound:5734-TETRAHYDROXYFLAVONE
- pdb-ccd:LU2
- pubmed:11478688
- pubmed:11897650
- pubmed:14574115
- pubmed:18720166
- pubmed:18946424
- pubmed:18991571
- pubmed:19263826
- pubmed:19509250
- pubmed:19854181
- pubmed:21899269
- pubmed:22391103
- pubmed:22749133
- pubmed:22794353
- pubmed:22842046
- pubmed:23035972
- pubmed:23229294
- pubmed:23574272
- pubmed:26020516
- pubmed:26322379
- pubmed:27595800
- pubmed:27764981
- pubmed:27853236
- pubmed:27878246
- pubmed:27879665
- pubmed:27886116
- pubmed:27919958
- pubmed:27927066
- pubmed:27959422
- pubmed:28004344
- pubmed:28029146
- pubmed:28031430
- pubmed:28035396
- pubmed:28067377
- pubmed:28069121
- pubmed:28071803
- pubmed:28090531
- pubmed:28096694
- pubmed:28101184
- pubmed:28101223
- pubmed:28110189
- pubmed:28111945
- pubmed:28112209
- pubmed:28113103
- pubmed:28166217
- pubmed:29423013
- pubmed:30624931
- pubmed:32883638
- reaxys:292084
- wikipedia.en:Luteolin
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from luteolin
Phenotype where environments contain luteolin
Phenotype modified by environments containing luteolin
Phenotype affecting luteolin
Human Disease Model